Literature DB >> 6829073

Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity.

C Shao-Hsien, I Lang, H Gunn, P Lydyard.   

Abstract

Concentrations of 0.1 to 10.0 micrograms of cyclosporin A (Cy A) per ml do not directly inhibit the lysis of 51Cr-labeled K562 target cells by human peripheral blood natural killer (NK) cells nor of antibody-coated chicken red blood cells by antibody-dependent cellular cytotoxicity (ADCC) effector cells. Pretreatment of effector cells with Cy A for 18 hr still failed to affect NK or ADCC effector function. However, induction of NK cell activity by overnight pretreatment of effector cells by polyinosinate-polycytidylate (PolyIC) is inhibited by as little as 1 micrograms of Cy A per ml. The mechanism of inhibition may involve a direct effect of Cy A on "induced" or "activated" NK cells or inhibition of the release of Poly IC-induced interferon from lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829073     DOI: 10.1097/00007890-198302000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

2.  The effect of 2'deoxyguanosine on human lymphocyte responses. II. 2'deoxyguanosine enhances PWM-induced B cell differentiation.

Authors:  A C Hanglow; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

Review 3.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Effect of Cyclosporin A on rat thymus: time course analysis by immunoperoxidase technique and flow cytofluorometry.

Authors:  M Tanaka; K Shinohara; T Fukumoto; H Tanaka; T Kaneko
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

5.  Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.

Authors:  Olivier Morteau; Samkeliso Blundell; Aron Chakera; Sophia Bennett; Charita M Christou; Philip D Mason; Richard J Cornall; Christopher A O'Callaghan
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

6.  Calcineurin-dependent lytic granule exocytosis in NK-92 natural killer cells.

Authors:  Arun T Pores-Fernando; Surabhi Gaur; Michelle Y Doyon; Adam Zweifach
Journal:  Cell Immunol       Date:  2008-08-30       Impact factor: 4.868

Review 7.  Cyclosporine: immunology, toxicity and pharmacology in experimental animals.

Authors:  A W Thomson; P H Whiting; J G Simpson
Journal:  Agents Actions       Date:  1984-10

8.  Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections.

Authors:  Sabine Huenecke; Claudia Cappel; Ruth Esser; Verena Pfirrmann; Emilia Salzmann-Manrique; Sibille Betz; Eileen Keitl; Julia Banisharif-Dehkordi; Shahrzad Bakhtiar; Christoph Königs; Andrea Jarisch; Jan Soerensen; Evelyn Ullrich; Thomas Klingebiel; Peter Bader; Melanie Bremm
Journal:  Front Immunol       Date:  2017-02-10       Impact factor: 7.561

9.  Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.

Authors:  Aislin C Meehan; Nicole A Mifsud; Thi H O Nguyen; Bronwyn J Levvey; Greg I Snell; Tom C Kotsimbos; Glen P Westall
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

Review 10.  Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Md Ashik Ullah; Geoffrey R Hill; Siok-Keen Tey
Journal:  Front Immunol       Date:  2016-04-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.